FundedIQ
Healthcare

Ascilion

Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.

www.ascilion.com Stockholm, Sweden 1-10 employees
Total raised
$2.2M
Rounds
1
Latest
Venture - Series Unknown
Sep 2025

Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.

Ascilion has raised $2.2M across 1 round. Its most recent round was a Venture - Series Unknown of $2.2M in Sep 2025. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Sep 24, 2025
Venture - Series Unknown
$2.2M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Ascilion is featured in

Similar companies

Cordance Medical

Cordance Medical develops radical therapy for a variety of CNS pathology.

Seed $8.0M
Bioactivx

Bioactivx is a healthcare firm that accelerates wound recovery, deliver better outcomes for conditions like ulcer, burns and cuts.

Seed $1.4M
DefEYE

DefEYE is an eye care startup that is expanding quickly with the goal of changing and customizing therapeutic procedures.

Seed $12.0M
Pluro Fertility and IVF

Pluro's goal is to create a single national platform for IVF and fertility treatment.

Series A $14.1M
Ki Health

Kihealth is launching the world's first blood test capable of identifying diabetes risk before symptoms emerge.

Seed $5.0M
MiMove

MiMove is a different kind of property portal. We are a regulated marketplace. That means that we visit and vet all real estate agencies before they can post their properties on MiMove – and exclude agencies who do not follow our rules. That is why we dare say that we are the safest marketplace for properties abroad.

Series Unknown $510k
Oblique Therapeutics

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.

Series Unknown $1.4M
Nivika

Nivika är ett Småländskt fastighetsbolag som förvärvar, förvaltar och utvecklar fastigheter primärt på expansiva orter i med en stabil hyresmarknad i södra Sverige. Vi är ett starkt team som med närhet, hög servicegrad och kvalitet bygger långsiktiga och starka kundrelationer. Vår arbetskultur präglas av starkt engagemang, glädje och ärlighet där korta beslutsvägar och entreprenöriell anda är hörnstenar. Det är mycket viktigt för oss att bibehålla den familjära stämningen med möjlighet för alla medarbetare att vara delaktiga på olika sätt.

Series Unknown $195M
Metacon AB

Metacon AB is a hydrogen energy systems provider that develops and manufactures energy systems for hydrogen, heat, and electricity production using catalytic steam reforming technology to generate hydrogen from biogas or hydrocarbons. Metacon also offers electrolysis systems and hydrogen refuelling solutions.

Series Unknown $7.9M
Ortelius

Tech development. Model driven tech. DTO. Digital Twin of an Organization. Solution areas are End-to-End Product Management, CIO Excellence, Growth and Innovation Management, Corporate Governance and Development

Series Unknown $50k
Wayout

Wayout offers an environmentally friendly, plug-and-play drinking water system that is locally sourced. It is 100% plastic-free and has a naturally balanced pH and mineral composition.

Series A $2.7M
Fika Jobs

is building a video-first hiring platform that combines AI interview agents with short-form video profiles.

Pre-Seed $4.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.